(Reuters) – Johnson & Johnson said on Tuesday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of a booster shot of its COVID-19 vaccine in people aged 18 years and older.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)
